Morgan Stanley
LNAI

Morgan Stanley’s Lunai Bioworks LNAI Stock Holding History

Morgan Stanley’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Sell
326
-1
-0.3% -$3 ﹤0.01% 7501
2026
Q1 		$1.06K Hold
327
– – ﹤0.01% 7425
2025
Q4 		$2.31K Sell
327
-1
-0.3% -$9 ﹤0.01% 7219
2025
Q3 		$3.73K Sell
328
-437
-57% -$8.43K ﹤0.01% 7163
2025
Q2 		$17.7K Sell
765
-1,844
-71% -$51.5K ﹤0.01% 6686
2025
Q1 		$113K Sell
2,609
-1,993
-43% -$128K ﹤0.01% 5953
2024
Q4 		$308K Buy
4,602
+144
+3% +$9.56K ﹤0.01% 5628
2024
Q3 		$172K Sell
4,458
-1,222
-22% -$84.7K ﹤0.01% 5802
2024
Q2 		$795K Buy
5,680
+989
+21% +$135K ﹤0.01% 5090
2024
Q1 		$995K Buy
4,691
+154
+3% +$41.5K ﹤0.01% 4957
2023
Q4 		$1.15M Buy
4,537
+2,866
+172% +$785K ﹤0.01% 4846
2023
Q3 		$598K Buy
1,671
+1,091
+188% +$166K ﹤0.01% 5084
2023
Q2 		$26.3K Sell
580
-365
-39% -$28K ﹤0.01% 6468
2023
Q1 		$69.2K Buy
945
+53
+6% +$4.66K ﹤0.01% 6151
2022
Q4 		$73.5K Sell
892
-969
-52% -$130K ﹤0.01% 6115
2022
Q3 		$269K Buy
1,861
+241
+15% +$43.9K ﹤0.01% 5583
2022
Q2 		$250K Buy
1,620
+958
+145% +$438K ﹤0.01% 5786
2022
Q1 		$437K Sell
662
-1,041
-61% -$554K ﹤0.01% 5493
2021
Q4 		$994K Sell
1,703
-6
-0.4% -$4.36K ﹤0.01% 5068
2021
Q3 		$920K Buy
1,709
+1,472
+621% +$719K ﹤0.01% 5101
2021
Q2 		$93K Sell
237
-2
-0.8% -$652 ﹤0.01% 6396
2021
Q1 		$67K Sell
239
-124
-34% -$36.5K ﹤0.01% 6211
2020
Q4 		$86K Buy
363
+340
+1,478% +$85.9K ﹤0.01% 5970
2020
Q3 		$6K Sell
23
-38
-62% -$12K ﹤0.01% 6416
2020
Q2 		$21K Buy
61
+38
+165% +$11.5K ﹤0.01% 5997
2020
Q1 		$6K Sell
23
-216
-90% -$64.2K ﹤0.01% 6156
2019
Q4 		$96K Buy
239
+217
+986% +$95.4K ﹤0.01% 5666
2019
Q3 		$9K Buy
22
+13
+144% +$4.97K ﹤0.01% 6245
2019
Q2 		$3K Sell
9
-38
-81% -$18.5K ﹤0.01% 6414
2019
Q1 		$26K Buy
+47
New +$27.5K ﹤0.01% 5927

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Morgan Stanley's LNAI Position: Q2 2026 in Review

Morgan Stanley reduced its Lunai Bioworks (LNAI) stake by 0.31% in Q2 2026, selling an estimated $3 and leaving 326 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #7501.

Morgan Stanley first reported a position in LNAI in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.15M in Q4 2023. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Morgan Stanley held 326 shares of Lunai Bioworks worth $1.07K as of Q2 2026.
  • Morgan Stanley sold 1 Lunai Bioworks share in Q2 2026, an estimated $3.
  • Lunai Bioworks made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7501 holding.
  • Morgan Stanley first reported a position in Lunai Bioworks in Q1 2019 and has held it in 30 quarters since.
  • Morgan Stanley's Lunai Bioworks position peaked at $1.15M in Q4 2023.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.